World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
12921
World Ranking
3048
National Ranking
205

Overview

Thomas Hünig is affiliated with the University of Würzburg in Germany, focusing on medical research with significant contributions in hematology and oncology. Their research encompasses multiple aspects of hematological malignancies, with a pronounced emphasis on multiple myeloma.

The primary fields of study pursued by Thomas Hünig include:

  • Medicine

Within this broad field, their work is specialized in several subfields:

  • Hematology
  • Oncology
  • Immunology
  • Molecular Biology
  • Immunology and Allergy

The main research topics addressed by Thomas Hünig are:

  • Multiple Myeloma Research and Treatments
  • Cell Adhesion Molecules Research
  • Chemokine receptors and signaling
  • Protein Degradation and Inhibitors
  • T-cell and B-cell Immunology
  • Lymphoma Diagnosis and Treatment
  • Peptidase Inhibition and Analysis

Their publication record reflects a focus on multiple myeloma and related hematologic diseases, with papers appearing in journals such as Haematologica, Leukemia, Blood Advances, British Journal of Haematology, and Clinical and Experimental Medicine. Notable recent papers include:

  • Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression, 2020, Haematologica
  • Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression, 2021, Leukemia
  • Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans, 2021, Blood Advances
  • Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma, 2022, British Journal of Haematology
  • STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure, 2023, Clinical and Experimental Medicine

Thomas Hünig has regularly published in certain clinical journals, most frequently in:

  • Clinical Lymphoma Myeloma & Leukemia
  • Blood
  • Haematologica
  • Leukemia
  • Clinical and Experimental Medicine

Collaborations have been a consistent aspect of their research, with frequent co-authors including:

  • Andreas Beilhack
  • Hermann Einsele
  • Leo Rasche
  • Antonio Giovanni Solimando
  • K. Martin Kortüm

Best Publications

  • Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting.

    Hubert Schorle;Thomas Holtschke;Thomas Hünig;Anneliese Schimpl

  • A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes.

    T Hünig;H J Wallny;J K Hartley;A Lawetzky

  • Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand

    T. Hünig;G. Tiefenthaler;K.-H. Meyer zum Büschenfelde;S. C. Meuer

  • A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.

    Magdalena Huber;Sylvia Heink;Henrike Grothe;Anna Guralnik

  • Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist

    Chia-Huey Lin;Thomas Hünig

  • The Human Immunodeficiency Virus Type 1 (HIV-1) Vpu Protein Interferes with an Early Step in the Biosynthesis of Major Histocompatibility Complex (MHC) Class I Molecules

    Thomas Kerkau;Igor Bacik;Jack R. Bennink;Jonathan W. Yewdell

  • Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms.

    Martina Wolf;Anneliese Schimpl;Thomas Hünig

  • Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis

    Niklas Beyersdorf;Stefanie Gaupp;Karen Balbach;Jens Schmidt

  • Topological Requirements and Signaling Properties of T Cell–activating, Anti-CD28 Antibody Superagonists

    Fred Lühder;Yun Huang;Kevin M. Dennehy;Christine Guntermann

  • CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28

    Michael Tacke;Gabriele Hanke;Thomas Hanke;Thomas Hünig

  • Regulatory T Cells Protect from Local and Systemic Bone Destruction in Arthritis

    Mario M. Zaiss;Benjamin Frey;Andreas Hess;Jochen Zwerina

  • Crystal structure of a soluble CD28-Fab complex

    E J Evans;R M Esnouf;R Manso-Sancho;Gilbert Rjc.

  • IMMUNOPATHOLOGY OF INTERLEUKIN (IL) 2-DEFICIENT MICE : THYMUS DEPENDENCE AND SUPPRESSION BY THYMUS-DEPENDENT CELLS WITH AN INTACT IL-2 GENE

    Susanne Kramer;Anneliese Schimpl;Thomas Hunig

  • Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412

    Paula S. Römer;Susanne Berr;Elita Avota;Shin Young Na

  • Specificity of cytotoxic T cells from athymic mice.

    T Hünig;M J Bevan

  • Differential thymus dependence of rat CD8 isoform expression.

    Nora Torres-Nagel;Elmar Kraus;Marion H. Brown;Georg Tiefenthaler

  • Triggering of T cell proliferation through CD28 induces GATA-3 and promotes T helper type 2 differentiation in vitro and in vivo.

    Marta Rodríguez-Palmero;Toyomichi Hara;Alexander Thumbs;Thomas Hünig

  • CD28 co-stimulation in T-cell homeostasis: a recent perspective

    Niklas Beyersdorf;Thomas Kerkau;Thomas Hünig

  • IL-2 and autoimmune disease.

    Anneliese Schimpl;Ingolf Berberich;Burkhardt Kneitz;Susanne Krämer

  • The cell surface molecule recognized by the erythrocyte receptor of T lymphocytes. Identification and partial characterization using a monoclonal antibody.

    Thomas Hunig

Frequent Co-Authors

Fred Lühder
Fred Lühder University of Göttingen
Klaus V. Toyka
Klaus V. Toyka University of Würzburg
Hermann Einsele
Hermann Einsele University of Würzburg
Ralf Gold
Ralf Gold Ruhr University Bochum
Georg Stingl
Georg Stingl Medical University of Vienna
Ivan D. Horak
Ivan D. Horak Freie Universität Berlin
Peter F. Zipfel
Peter F. Zipfel Friedrich Schiller University Jena
Timothy A. Springer
Timothy A. Springer Boston Children's Hospital
Michael L. Dustin
Michael L. Dustin University of Oxford
Lars Nitschke
Lars Nitschke University of Erlangen-Nuremberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related online degrees can open diverse career pathways in healthcare and research. Those seeking to specialize in mental health nursing might consider programs like the cheapest online pmhnp programs. These affordable options help professionals gain expertise in psychiatric care, complementing immunological knowledge when addressing neuroimmune disorders.

Nurse Practitioners (NPs) with a background in immunology can boost their earning potential by focusing on specialties with high demand. According to data on highest paid dnp specialties, acute care and specialty nursing roles tend to offer some of the best compensation, making them attractive options for advanced practice nurses.

If you are already a Family Nurse Practitioner (FNP) and want to work more closely with patients requiring immunological expertise, pursuing an acute care certification for fnp can be a strategic career move. This certification enables you to manage complex health conditions where immune function is critical.

For those looking to fast-track their education, multiple accelerated np programs offer flexible online formats designed to quickly prepare students for Nurse Practitioner roles in various specialties, including immunology-related fields. These programs provide an efficient pathway to enter the workforce and impact patient care.

Best Scientists Citing Thomas Hünig

Trending Scientists

Recently Published Articles